Literature DB >> 23179943

Temporal evolution of administered activity in cardiac gated SPECT and patients' effective dose: analysis of an historical series.

C Marcassa1, O Zoccarato, P Calza, R Campini.   

Abstract

PURPOSE: Myocardial perfusion imaging contributes >20 % of the average medical radiation exposure to the population in the USA. Imaging protocols able to achieve a radiation exposure ≤9 mSv in 50 % of the studies by 2014 have been recommended. The aim of this study was to analyse the temporal evolution of administered activities in patients scheduled for dual-day (99m)Tc tracer gated single photon emission computed tomography (SPECT) and to compare different dose administration protocols in terms of patients' effective dose.
METHODS: Patients evaluated from 1 July 2002 to 31 January 2012 were allocated according to the protocol adopted: group 1: fixed activity according to diagnostic reference level: 740 MBq up to 80 kg (adapted for weight <60 kg); 900 MBq 80-100 kg, 1,110 MBq >100 kg, standard filtered back-projection (FBP) reconstruction; group 2: weight-adjusted activity: 8 MBq/kg up to 1,110 MBq, standard FBP reconstruction; and group 3: 4 MBq/kg, UltraSPECT wide beam reconstruction (WBR) reconstruction. A dual-head Anger camera (GE Helix) was used.
RESULTS: A total of 9,060 patients were allocated to different groups: 4,751 in group 1, 2,844 in group 2 and 1,465 in group 3. The stress + rest administered activity was 1,617 ± 180 in group 1, 1,136 ± 260 in group 2 and 682 ± 164 MBq in group 3 (all p < 0.001). Patients' effective dose was 13.7 ± 3 in group 1, 9.5 ± 2.8 in group 2 and 5.7 ± 1.6 mSv in group 3 (all p < 0.001). The 50th percentile was 12.6 in group 1, 9.1 in group 2 and 5.3 mSv in group 3. The effective dose received by the dedicated cardiologists was 2.1, 1.5 and 1.0 μSv/exam in group 1, group 2 and group 3 periods, respectively (all p < 0.001).
CONCLUSION: A significant reduction over time in the administered activity for gated SPECT was achieved; accordingly, a significant reduction in patients' exposure was obtained. A simple weight-adjusted strategy with 8 MBq/kg immediately fulfils the recommendations to limit exposure. In selected group 3 patients, a stress-only strategy allows for studies with <3 mSv exposure. Thus, at least the adoption of a new reconstruction algorithm is strongly encouraged, and suggested tracer activities for cardiac gated SPECT are to be revised.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23179943     DOI: 10.1007/s00259-012-2287-5

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  23 in total

1.  The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103.

Authors: 
Journal:  Ann ICRP       Date:  2007

2.  High diagnostic accuracy of low-dose gated-SPECT with solid-state ultrafast detectors: preliminary clinical results.

Authors:  Alessia Gimelli; Matteo Bottai; Dario Genovesi; Assuero Giorgetti; Fabio Di Martino; Paolo Marzullo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-09-02       Impact factor: 9.236

3.  Multicenter trial of high-speed versus conventional single-photon emission computed tomography imaging: quantitative results of myocardial perfusion and left ventricular function.

Authors:  Tali Sharir; Piotr J Slomka; Sean W Hayes; Marcelo F DiCarli; Jack A Ziffer; William H Martin; Dalia Dickman; Simona Ben-Haim; Daniel S Berman
Journal:  J Am Coll Cardiol       Date:  2010-05-04       Impact factor: 24.094

4.  Reduced isotope dose with rapid SPECT MPI imaging: initial experience with a CZT SPECT camera.

Authors:  W Lane Duvall; Lori B Croft; Tapan Godiwala; Eric Ginsberg; Titus George; Milena J Henzlova
Journal:  J Nucl Cardiol       Date:  2010-11-12       Impact factor: 5.952

Review 5.  Cardiac hybrid imaging.

Authors:  Oliver Gaemperli; Antti Saraste; Juhani Knuuti
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2011-11-17       Impact factor: 6.875

Review 6.  Advances in nuclear cardiac instrumentation with a view towards reduced radiation exposure.

Authors:  Piotr J Slomka; Damini Dey; W Lane Duvall; Milena J Henzlova; Daniel S Berman; Guido Germano
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

7.  Ordered subset expectation maximization and wide beam reconstruction "half-time" gated myocardial perfusion SPECT functional imaging: a comparison to "full-time" filtered backprojection.

Authors:  E Gordon DePuey; Ramesh Gadiraju; John Clark; Linda Thompson; Frank Anstett; Shuli C Shwartz
Journal:  J Nucl Cardiol       Date:  2008-04-24       Impact factor: 5.952

8.  Exposure to low-dose ionizing radiation from medical imaging procedures.

Authors:  Reza Fazel; Harlan M Krumholz; Yongfei Wang; Joseph S Ross; Jersey Chen; Henry H Ting; Nilay D Shah; Khurram Nasir; Andrew J Einstein; Brahmajee K Nallamothu
Journal:  N Engl J Med       Date:  2009-08-27       Impact factor: 91.245

9.  Normal stress-only versus standard stress/rest myocardial perfusion imaging: similar patient mortality with reduced radiation exposure.

Authors:  Su Min Chang; Faisal Nabi; Jiaqiong Xu; Umara Raza; John J Mahmarian
Journal:  J Am Coll Cardiol       Date:  2009-11-13       Impact factor: 24.094

10.  Radiation dose to patients from radiopharmaceuticals. Addendum 3 to ICRP Publication 53. ICRP Publication 106. Approved by the Commission in October 2007.

Authors: 
Journal:  Ann ICRP       Date:  2008
View more
  9 in total

1.  Comparative analysis of full-time, half-time, and quarter-time myocardial ECG-gated SPECT quantification in normal-weight and overweight patients.

Authors:  M Lecchi; I Martinelli; O Zoccarato; C Maioli; Giovanni Lucignani; A Del Sole
Journal:  J Nucl Cardiol       Date:  2016-02-24       Impact factor: 5.952

2.  The long way to dose reduction in myocardial perfusion imaging.

Authors:  Michela Lecchi; Angelo Del Sole
Journal:  J Nucl Cardiol       Date:  2017-06-30       Impact factor: 5.952

3.  It's about time we think about lowering radiation dose in obese patients too.

Authors:  Daniel A Kim; Mary Beth Farrell; Scott D Jerome
Journal:  J Nucl Cardiol       Date:  2016-08-19       Impact factor: 5.952

4.  Advances in image reconstruction software in nuclear cardiology: Is all that glitters gold?

Authors:  Claudio Marcassa; Orazio Zoccarato
Journal:  J Nucl Cardiol       Date:  2016-05-24       Impact factor: 5.952

5.  Uncontrolled risk factors and worsening perfusion pattern on SPECT myocardial perfusion imaging in medically treated patients with stable chronic ischaemic heart disease.

Authors:  Claudio Marcassa; Riccardo Campini; Paolo Calza; Orazio Zoccarato
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-03-12       Impact factor: 9.236

6.  Multiple opportunities to reduce radiation dose from myocardial perfusion imaging.

Authors:  Andrew J Einstein
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05       Impact factor: 9.236

7.  Nuclear cardiology practice and associated radiation doses in Europe: results of the IAEA Nuclear Cardiology Protocols Study (INCAPS) for the 27 European countries.

Authors:  Oliver Lindner; Thomas N B Pascual; Mathew Mercuri; Wanda Acampa; Wolfgang Burchert; Albert Flotats; Philipp A Kaufmann; Anastasia Kitsiou; Juhani Knuuti; S Richard Underwood; João V Vitola; John J Mahmarian; Ganesan Karthikeyan; Nathan Better; Madan M Rehani; Ravi Kashyap; Maurizio Dondi; Diana Paez; Andrew J Einstein
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-12-19       Impact factor: 9.236

8.  Use of myocardial perfusion imaging and estimation of associated radiation doses in Germany from 2005 to 2012.

Authors:  O Lindner; F M Bengel; M Hacker; W Schäfer; W Burchert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-12       Impact factor: 9.236

Review 9.  Myocardial perfusion scintigraphy dosimetry: optimal use of SPECT and SPECT/CT technologies in stress-first imaging protocol.

Authors:  M Lecchi; S Malaspina; C Scabbio; V Gaudieri; A Del Sole
Journal:  Clin Transl Imaging       Date:  2016-10-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.